Unlock instant, AI-driven research and patent intelligence for your innovation.

Establishment and application of liver cancer prediction model based on differentiated expression miRNA in fucosylated extracellular vesicles

A fucosylation and differentiation technology, applied in the field of biomedicine, can solve the problems that early diagnosis liquid biopsy is still in the early research stage, achieve excellent clinical application performance, avoid limitations, and improve the effect of predictive ability

Pending Publication Date: 2022-05-27
北京尧景基因技术有限公司
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Reports have shown that the presence of glycosylation is involved in the biogenesis of EVs, cell recognition, and the efficient uptake of EVs by recipient cells. Most tumor-associated glycan changes have been identified to be enriched in cancer EVs. Glycosylated EVs Like the "sugar-coated bullets" launched by tumor cells, it may be used to improve the current cancer diagnosis path and become an important biomarker for early diagnosis of cancer; circulating tumor cells (CTC), circulating tumor DNA (ctDNA), extracellular vesicles Extracellular vesicles are known as the troika of liquid biopsy for early diagnosis of tumors. Among them, CTC and ctDNA are widely studied and applied. The use of extracellular vesicles in liquid biopsy for early diagnosis of tumors is still in the early research stage, and there is no direct application of glycosylated extracellular vesicles. Technology and products of vesicle-related markers applied to liquid biopsy for early diagnosis of tumors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Establishment and application of liver cancer prediction model based on differentiated expression miRNA in fucosylated extracellular vesicles
  • Establishment and application of liver cancer prediction model based on differentiated expression miRNA in fucosylated extracellular vesicles
  • Establishment and application of liver cancer prediction model based on differentiated expression miRNA in fucosylated extracellular vesicles

Examples

Experimental program
Comparison scheme
Effect test

Embodiment example 1

[0060] Implementation Case 1: Subject Sample Information

[0061] In this implementation case, the subject sample information includes three sample sets, including:

[0062] Retrospective sample collection: 61 samples from patients with liver cancer, 24 samples from patients with other liver diseases other than liver cancer, and 30 samples from healthy people without liver-related diseases;

[0063] RT-PCR verification sample collection: 16 samples from patients with liver cancer, 16 samples from patients with other liver diseases other than liver cancer, and 16 samples from healthy people without liver-related diseases;

[0064] Prospective sample collection: 52 samples from patients with liver cancer, 30 samples from patients with other liver diseases other than liver cancer, and 23 samples from healthy people without liver-related diseases;

[0065] The above sample collection is used for the subsequent implementation cases of glycosylated extracellular vesicles isolation,...

Embodiment example 2

[0067] Example 2: Isolation and enrichment of fucosylated extracellular vesicles

[0068] In this example, in order to better illustrate the separation and enrichment method and effect of fucosylated extracellular vesicles, conventional differential ultracentrifugation (UC) was used to separate total extracellular vesicles in the sample, and GlyExo- The Capture sugar capture technology isolates and enriches fucosylated extracellular vesicles.

[0069] 1. Use differential ultracentrifugation to separate (UC) total extracellular vesicles from serum samples

[0070] (1) After the serum samples were thawed at 37°C, centrifuge at 3,000 × g for 10 minutes to remove cell debris;

[0071] (2) Dilute the 500 μl serum sample separated in step (1) with 20 times the volume of phosphate buffered saline (PBS), and use a 0.22 μm diameter filter to remove large particles in the serum sample;

[0072] (3) Ultracentrifugation at 100,000 × g for 90 min at 4°C using a 100-type TI rotor with a m...

Embodiment example 3

[0081] Example 3: Identification of extracellular vesicles after isolation

[0082] The total extracellular vesicles isolated by conventional differential ultracentrifugation and the fucosylated extracellular vesicles isolated and enriched by GlyExo-Capture sugar capture technology in Example 2 were analyzed by transmission electron microscopy. , TEM) and nanoparticle tracking analysis (NTA) to evaluate the morphology and size distribution of extracellular vesicles; extracellular vesicles were further verified by Western blot and Exoview analysis techniques. Among them: Transmission Electron Microscopy (TEM) was used to observe the morphology and structure of extracellular vesicles and measure their size; Nanoparticle Tracking Analysis (NTA) was used to measure the diameter distribution and number of EVs particle populations; Western Blot and Exoview analysis techniques identified Marker proteins on the surface of extracellular vesicles to identify whether the isolates are ext...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of biological medicine, in particular to establishment and application of a liver cancer prediction model based on differentiated expression miRNA in fucosylated extracellular vesicles. Fucosylated extracellular vesicles in a sample are rapidly and effectively captured through a GlyExo sugar capture technology; the combination of differentially expressed miRNAs of liver cancer patient samples can be effectively obtained through an NGS sequencing technology and a signal analysis technology, 75 differentially expressed miRNAs are involved in total, liver cancer samples and non-liver cancer samples can be effectively distinguished through univariate analysis or model combinatorial analysis of the differentially expressed miRNAs, and therefore, the liver cancer detection accuracy is improved. The important clinical application prospect of the miRNA based on the glycosylation extracellular vesicles in the liver cancer diagnosis field is fully embodied. The invention provides a brand new detection strategy completely different from the existing detection method for early diagnosis of liver cancer, can effectively avoid the defects of the existing detection method, and has higher clinical value of comprehensive application.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the establishment and application of a liver cancer prediction model based on differentially expressed miRNAs (DEMs for short) in fucosylated extracellular vesicles. Background technique [0002] In recent years, there has been increasing interest in assessing circulating biomarkers, especially free miRNAs, miRNAs, in blood. It can detect cancer by repeating and non-invasive sampling to obtain early molecular information about tumorigenesis. However, the expression of blood free miRNAs is highly heterogeneous and it may originate from cancer cells or other cells. Therefore, blood free miRNAs may not be representative of the miRNA expression profiles of cancer cells, especially in the early stages of tumors. Therefore, reliability and stability are major challenges in the direct use of serum miRNAs for early cancer screening. [0003] Extracellular vesicles (EVs) are nanoscale partic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886C12Q1/6869C12Q1/6851C12Q1/6813C12N15/11A61K47/46A61P35/00G16B20/00
CPCC12Q1/6886C12Q1/6869C12Q1/6851C12Q1/6813A61K47/46A61P35/00G16B20/00C12Q2600/158C12Q2600/178C12Q2535/122C12Q2531/113
Inventor 林长青郝昆高琦杜文谦孙丽娟李艳召
Owner 北京尧景基因技术有限公司